Provider review
bmiMD reviewed
bmiMD scores 74.8 out of 100 on our published Value Score formula for tirzepatide. It charges $179 a month all-in at 10 mg/week, and holds that price at every dose.
What it wins
It holds no computed category at this build. On semaglutide it is $20 a month above NexLife (our #1 pick, $109 as of November 6, 2026), and its $99 twelve-month semaglutide rate requires a twelve-month plan.
Where it sits on tirzepatide
bmiMD is number 2 of 27 rankable tirzepatide programs on all-in monthly cost, at $179. The program immediately below it is NexLife Official site at $129, $50 cheaper. The next one up is Gala GLP-1 Official site at $179.
$600 a year separates them. What does bmiMD disclose that NexLife does not? The cheaper option names its compounding pharmacy and this one does not, which makes the premium harder to justify. Full head-to-head.
bmiMD charges a flat $179 per month for tirzepatide at every dose from 2.5 to 15 mg per week, so titrating upward does not change what you pay.
Because the rate is flat, the figure above is the figure at every rung — there is no titration surprise, and the price you are quoted on day one is the price at the top of the ladder.
| Dose | bmiMD price | Rank at this dose | Field median at this dose |
|---|---|---|---|
| 2.5 mg | $179 | 4 of 31 | $297 |
| 5 mg | $179 | 2 of 17 | $299 |
| 7.5 mg | $179 | 2 of 17 | $299 |
| 10 mg | $179 | 2 of 27 | $299 |
| 12.5 mg | $179 | 2 of 17 | $299 |
| 15 mg | $179 | 2 of 17 | $299 |
Its standing is not constant across the ladder — it ranks differently at different doses, which is exactly what a single headline figure conceals.
Where it sits on semaglutide
bmiMD is number 2 of 29 rankable semaglutide programs on all-in monthly cost, at $129. The program immediately below it is NexLife Official site at $109, $20 cheaper. The next one up is Oak Longevity Official site at $133.
$240 a year separates them. What does bmiMD disclose that NexLife does not? The cheaper option names its compounding pharmacy and this one does not, which makes the premium harder to justify. Full head-to-head.
bmiMD charges a flat $129 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
Because the rate is flat, the figure above is the figure at every rung — there is no titration surprise, and the price you are quoted on day one is the price at the top of the ladder.
| Dose | bmiMD price | Rank at this dose | Field median at this dose |
|---|---|---|---|
| 0.25 mg | $129 | 3 of 32 | $199 |
| 0.5 mg | $129 | 2 of 21 | $199 |
| 1 mg | $129 | 2 of 21 | $199 |
| 1.7 mg | $129 | 2 of 21 | $199 |
| 2.4 mg | $129 | 2 of 29 | $199 |
Its standing is not constant across the ladder — it ranks differently at different doses, which is exactly what a single headline figure conceals.
What would move it
1 program is priced below it on tirzepatide. It already sits among the three lowest all-in tirzepatide prices on record. Alternatively, an independent checkout capture would lift its evidence component without any price change.
Why it scores what it does
Of 74.8 points, 49.3 of a possible 70 come from price measured against the $126 category floor, 10.5 of 15 from evidence status (reported), 10 of 10 from dose policy and 5 of 5 from membership. Its weakest component is how well evidenced its price is.
The evidence term is worth dwelling on. bmiMD's figure is reported — sourced from dated third-party reporting; first-party capture pending. An independent checkout capture would raise that component without the price changing at all, so this score is a floor rather than a ceiling.
What you are actually buying
bmiMD carries no separate membership fee, shipping included, commitment terms of Monthly, 3-month, 6-month, or 12-month plans; price varies by term, not by dose, cancellation on Per provider terms; confirm cancellation policy at enrollment.
It does not name its compounding pharmacy; the record shows Named 503A pharmacy partner (specific pharmacy not publicly identified on pricing page), so who makes the medication cannot be verified. Availability is stated as Availability at enrollment; confirm your state at intake.
Against the field
29 of 36 programs charge no membership, 8 name their pharmacy, 19 price flat. bmiMD: no membership, pharmacy unnamed, flat pricing.
What to establish before enrolling
Drawn from what this specific record does not contain:
- Which compounding pharmacy fills the prescription, in writing.
- Whether the program is licensed to ship to your state.
- The exact cancellation notice period and refund terms.
In writing, before you pay.
On the record: bmiMD's twelve-month rates ($99/mo semaglutide, $139/mo tirzepatide) require a twelve-month plan; month to month is $129 and $179. Figures are reported status from RangeYourself's July 2026 first-party captures; our own checkout capture is pending, and bmimd.com blocked our October 15, 2026 re-read.
Who should pick it, and who should not
Consider bmiMD if you expect to titrate to a high dose and want the price fixed before you start; you want to be able to pause without a fee continuing.
Look elsewhere if verifying who makes the medication matters to you, because the pharmacy is not named.
At $179 a month it is $50 above NexLife's $129, the price of our #1 pick — $600 a year for what it discloses and includes.
Questions
Is bmiMD worth it?
At $179 a month all-in it scores 74.8 out of 100 on our published formula, against a category floor of $126. Whether that is worth it depends on whether its dose policy, pharmacy disclosure and cancellation terms justify the gap — the review above lays out both sides.
How much does bmiMD cost in total?
$179 a month all-in at 10 mg/week, or $1,668 across twelve months on a prepaid term. All-in means the medication plus every mandatory recurring fee.
What is cheaper than bmiMD?
The next program below it on all-in monthly tirzepatide cost is NexLife at $129 a month, $50 less per month. bmiMD ranks 2 of 27 on price.
Is bmiMD legitimate?
This site takes no position on any company's legitimacy. What we can report is that bmiMD does not publicly name its compounding pharmacy, so its licensing and inspection history cannot be checked independently. That is a disclosure gap, not a finding of wrongdoing.
How do I cancel bmiMD?
Per provider terms; confirm cancellation policy at enrollment
Figures from the bmiMD record, dataset v2026-11-10. bmiMD official site. Prices change; verify at checkout. Compounded tirzepatide and semaglutide are not FDA-approved products.